REMS Modification Delays Approval of Ravulizumab for NMOSD
The FDA has issued a Complete Response Letter to AstraZeneca regarding the sBLA for ravulizumab-cwvz for neuromyelitis optica spectrum disorder.
Source: neurologyadvisor.com
Page 37 - Boxed Warning News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Boxed Warning Today - Breaking & Trending Today
REMS Modification Delays Approval of Ravulizumab for NMOSD
The FDA has issued a Complete Response Letter to AstraZeneca regarding the sBLA for ravulizumab-cwvz for neuromyelitis optica spectrum disorder.
Source: empr.com
Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023
Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW...
Source: marketscreener.com
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Sep 6, 2023--
Source: eagletribune.com
Brixadi Now Available for Weekly or Monthly Administration to Treat Opioid Use Disorder
Brixadi® (buprenorphine) extended-release subcutaneous injection is now available for the treatment of moderate to severe opioid use disorder.
Source: empr.com